Norwegian version of this page

Pharmaceutical microbiology and immunity

We aim to understand how microorganisms contribute to our health and to the development of disease in a One Health perspective, and to contribute to the development of novel antimicrobial strategies for important human and animal pathogens. Studies are conducted at an organismic (host-microbe, microbiome), cellular and molecular level, and the research focuses on how changes and variability in microbial genomes affect cellular and viral processes, including resistance to antimicrobial agents, and how this knowledge may benefit society e.g. by contributing to the development of novel antimicrobial strategies including vaccine and diagnostic tools.

Microorganisms studied within Pharmaceutical microbiology and immunity include infectious salmon anemia virus, Klebsiella pneumoniae, Francisella noatuensis, Vibrio cholerae, and Bacillus cereus group bacteria.

Read more about our research within Pharmaceutical microbiology and immunity at our research group web sites:

Bacterial Evolution and Disease (BadBugs) - Økstad group

Microbial pathogenesis, vaccines and antimicrobial resistance (MicroPath) - Winther-Larsen group

Virus and vaccines - Gjøen group

OMICS - Rounge group

 

The research group contributes towards the United Nations (UN) sustainability developmental goals.

Sustainable development goals: 2: Zero hunger 3: Good health and well-being 9: Industry, innovation and infrastructure 12: Responsible consumption and production 14: Life below water 17: Partnerships for the goals

About the Laboratory

Pharmaceutical microbiology and immunity was initiated under the name Laboratory for Microbial Dynamics (LaMDa) as an emerging top-tier research laboratory at the Faculty of Mathematics and Natural Sciences (MN faculty) in 2008, and was later granted the strategic MN faculty initiative CIME (Center for Integrative Microbiology and Evolution, now discontinued). The laboratory is closely associated with several other research groups working within molecular microbiology at the MN Faculty, as well as at other UiO Faculties (Medicine, Odontology), and with other Norwegian and international collaborators e.g. through the National PhD school in Infectious Biology and Antimicrobials, IBAThe research is centered around several topics within microbial research. 

The laboratory currently receives research funding through the Research Council of Norway, the Norwegian Cancer Society, EU, and internal grants from the University of Oslo (from The Faculty of Mathematics and Natural Sciences, the Department of Pharmacy and University of Oslo Life Sciences).

Our goal is threefold:

1) To perform first class science

2) To create an environment where younger students and scientists can learn and develop into more mature scientists

3) Explore the possibilities of translating our research into new products for the benefit of society 

Research group leaders

Pharmaceutical microbiology and immunity is hosted by four principal investigators (PI) with permanent affiliation to the Department of Pharmacy:

Professor Ole Andreas Løchen Økstad 

Professor Hanne Cecilie Winther-Larsen 

Professor Tor Gjøen 

Professor Trine Ballestad Rounge 

 

Funded by The Research Council of Norway

Published Nov. 8, 2010 11:49 PM - Last modified Feb. 13, 2024 5:48 PM